Successful Treatment of Metastatic Lung Adenocarcinoma With Lazertinib: A Case Report

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Lazertinib: A Selective EGFR Mutant Inhibitor to Treat Non-Small Cell Lung Cancer2026
2. 2Real‐world study of lazertinib as second‐line or greater treatment in advanced non‐small cell lung cancer2024 · 1 citations
3. 3Central Nervous System Activity of Lazertinib in EGFR ‐Mutated NSCLC With Prior EGFR TKI Exposure: A Pooled Analysis of KCSG‐LU20‐15 and LU21‐012026
4. 4Weekly Afatinib in the Treatment of Advanced Non-small Cell Lung Cancer with EGFR-G719C Mutation Followed by Lobectomy: A Case Report2024
5. 5Sequential tyrosine kinase inhibitor therapy for EGFR L747P-mutated lung adenocarcinoma in a renal transplant recipient: a 24-month case report2025